[Is it possible to prevent type 2 diabetes?]

M Laville1

  • 1Service d'Endocrinologie, Hôpital Edouard-Herriot F-69437 LYON Cedex 3. martine.laville@chu-lyon.fr

Annales D'Endocrinologie
|August 12, 2003
PubMed

Insights

Lifestyle changes and medications like metformin can prevent or delay type 2 diabetes in high-risk individuals. These interventions offer practical strategies for managing impaired glucose tolerance and preventing disease onset.

Area of Science:

  • Endocrinology and Metabolism
  • Preventive Medicine
  • Clinical Research

Background:

  • Type 2 diabetes is a growing global health concern.
  • Individuals with impaired glucose tolerance are at high risk for developing type 2 diabetes.
  • Effective strategies for prevention and delay are crucial.

Purpose of the Study:

  • To review recent long-term studies on type 2 diabetes prevention.
  • To discuss the efficacy of lifestyle interventions and pharmacological treatments.
  • To explore the practical implications of these findings for high-risk populations.

Main Methods:

  • Analysis of four major prospective randomized long-term studies: Diabetes Prevention Study, Diabetes Prevention Program, STOP-NIDDM trial, and XENDOS Study.
  • Evaluation of interventions including dietary changes, weight reduction, increased physical activity, and drug treatments (metformin, acarbose, orlistat).

Main Results:

  • Consistent evidence demonstrates that lifestyle modifications can significantly delay or prevent type 2 diabetes.
  • Pharmacological interventions, specifically metformin, acarbose, and orlistat, also show effectiveness in preventing or delaying disease onset.
  • These interventions are particularly beneficial for individuals identified as high-risk with impaired glucose tolerance.

Conclusions:

  • Preventive strategies, encompassing both lifestyle changes and specific drug therapies, are viable for high-risk individuals.
  • The findings provide a strong basis for implementing public health initiatives and clinical guidelines for diabetes prevention.
  • Further discussion on the practical application of these results is warranted for effective diabetes management.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...